It can be seen from analysis on major blood grouping analyzer-related patent applications published in the 3 years from 2018 to 2021 that benefited from the basically stable original technologies of the industry; domestic enterprises have continuously increased R&D inputs, constantly improved technical innovation capability, made breakthroughs in many technologies, and developed a batch of core components of instruments with independent intellectual property rights through follow-on R&D strategy.

China plans to accelerate the establishment of a tiered healthcare delivery system, focusing on strengthening primary-level medical capacity to manage common and chronic diseases such as hypertension and diabetes, authorities said.

On June 16, 2021, AVE Science & Technology Co. Ltd. was listed on the Sci-Tech innovation board. The number of A shares publicly issued this time is 17 million shares, the issue price is 14.71 yuan/share, the opening price is 38.24 yuan/share, and the maximum increase at the time of press is 207%.

On June 13, local time, G7 summit closed in Cornwall, England. According to the Global Times previously reported, Euro news reporter Jack Parrock (Jack Parrock) posted a picture on social media and found that the lateral flow COVID tests we have to do every day at G7 summit are “made in China”.

The landscape of the medical device industry is changing.

On June 2, "Fortune" released the latest 2021 US 500 list. Among them, 9 companies in the medical device industry were on the list, and 5 companies involved in IVD business were also on the list.

Thermo Fisher Scientific on Monday announced two comarketing agreements and a research collaboration involving its mass spectrometry, sample preparation, and analysis software technologies.

Recently, Sansure Biotech Inc.'s new product launch conference and business partner recruitment conference was held in Changsha, China. More than 1,500 people participated in the conference and more than 120 dealers signed agreement.

A key meeting of the Communist Party of China unveiled on the last day of May a policy that would allow all couples to have up to three children, in place of the current universal two-child policy, in a bid to cope with an increasingly aging society.

June 1st, WHO validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, which is produced by the Beijing-based pharmaceutical company Sinovac.

On May 31, 2021, Reliable Medical Technology CO., Ltd. (hereinafter referred to as "Reliable Med") issued an announcement announcing that the company had recently completed A+ round of financing of tens of millions of yuan.

On May 28, the website of the Chinese Center for Disease Control and Prevention published the "General Information on Adverse Reaction Monitoring of COVID-19 Vaccine Vaccination" jointly published by the center and the National Adverse Drug Reaction Monitoring Center.